NRG BN007

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Brain

Status:

New, Open

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma

NCT#04396860